Search results
Results from the WOW.Com Content Network
MMDA (3-methoxy-4,5-methylenedioxyamphetamine; 5-methoxy-MDA) is a psychedelic and entactogen drug of the amphetamine class. It is an analogue of lophophine, MDA, and MDMA.. MMDA was described by Alexander Shulgin in his book PiHKAL.
Lykos Therapeutics, formerly known as the MAPS Public Benefit Corporation (MAPS PBC), is a public benefit corporation (PBC) that is developing MDMA ("ecstasy") as a potential medicine. [1] It was founded and is considerably owned by the non-profit Multidisciplinary Association for Psychedelic Studies (MAPS). [ 1 ]
Tablets sold as ecstasy sometimes contain 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxyethylamphetamine (MDEA), other amphetamine derivatives, caffeine, opiates, or painkillers. [8] Some tablets contain little or no MDMA. [8] [10] [77] The proportion of seized ecstasy tablets with MDMA-like impurities has varied annually and by ...
3,4-Methylenedioxy-N-ethylamphetamine (MDEA; also called MDE and colloquially, Eve) is an empathogenic psychoactive drug.MDEA is a substituted amphetamine and a substituted methylenedioxyphenethylamine.
Midomafetamine (MDMA; "ecstasy") – serotonin, norepinephrine, and dopamine releasing agent, weak serotonin 5-HT 2A, 5-HT 2B, 5-HT 2C receptor agonist, entactogen, and weak psychedelic hallucinogen – post-traumatic stress disorder, alcoholism, social anxiety in autism – Multidisciplinary Association for Psychedelic Studies (MAPS), Lykos ...
MDMA (ecstasy) is a popular club drug in the rave and electronic dance music scenes and in nightclubs.It is known under many nicknames, including "e" and "Molly". MDMA is often considered the drug of choice within the rave culture and is also used at clubs, festivals, house parties and free parties. [8]
meta-Chlorophenylpiperazine (mCPP) is a psychoactive drug of the phenylpiperazine class. It was initially developed in the late-1970s and used in scientific research before being sold as a designer drug in the mid-2000s.
Difluoromethylenedioxyamphetamine (DFMDA, DiFMDA) is a substituted derivative of 3,4-methylenedioxyamphetamine (MDA), which was developed by Daniel Trachsel and ...